The Nonantibiotic Small Molecule Cyslabdan Enhances the Potency of β-Lactams against MRSA by Inhibiting Pentaglycine Interpeptide Bridge Synthesis

• Nobuhiro Koyama,

  Affiliation Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan

  ⨯
• Yuriko Tokura,

  Affiliation Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan

  ⨯
• Daniela Münch,

  Affiliation Institute of Medical Microbiology, University of Bonn, Bonn, Germany

  ⨯
• Hans-Georg Sahl,

  Affiliation Institute of Medical Microbiology, University of Bonn, Bonn, Germany

  ⨯
• Tanja Schneider,

  Affiliation Institute of Medical Microbiology, University of Bonn, Bonn, Germany

  ⨯
• Yoshio Shibagaki,

  Affiliation Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan

  ⨯
• Haruo Ikeda,

  Affiliation Kitasato Institute for Life Sciences, Kitasato University, Kanagawa, Japan

  ⨯
• Hiroshi Tomoda

  * E-mail: tomodah@pharm.kitasato-u.ac.jp

  Affiliation Graduate School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan

  ⨯